This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Centrella, M Articles by Canalis, E Search for Related Content PubMed PubMed Citation Articles by Centrella, M Articles by Canalis, E

 Previous Article  |  Next Article 

Mol Cell Biol. 1991 September; 11(9): 4490-4496

Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone.

Department of Research, Saint Francis Hospital and Medical Center, Hartford, Connecticut 06105.

ABSTRACT

Transforming growth factor beta (TGF-beta) enhances replication and bone matrix protein synthesis and associates with distinct binding sites in osteoblast-enriched cultures from fetal rat bone. In the organism high levels of or sustained exposure to glucocorticoids alters bone cell activity and decreases bone mass, effects that may be mediated in part by changes in local TGF-beta actions in skeletal tissue. Preexposure of osteoblast-enriched cultures to 100 nM cortisol reduced the stimulatory effects of TGF-beta 1 on DNA and collagen synthesis by 40 to 50%. Binding studies showed that cortisol moderately enhanced total TGF-beta 1 binding, but chemical cross-linking and polyacrylamide gel electrophoretic analysis revealed an increase only within Mr 250,000 (type III) TGF-beta-binding complexes, which are thought to represent extracellular TGF-beta storage sites. In contrast, a decrease in TGF-beta 1 binding was detected in Mr 65,000 (type I) and 85,000 (type II) complexes, which have been implicated as signal-transducing TGF-beta receptors. Our present studies therefore indicate that glucocorticoids can decrease the anabolic effects of TGF-beta 1 in bone, and these may occur in part by a redistribution of its binding toward extracellular matrix storage sites. Alterations of this sort could contribute to bone loss associated with glucocorticoid excess.

This article has been cited by other articles:

• McCarthy, T. L., Pham, T. H., Knoll, B. I., Centrella, M. (2007). Prostaglandin E2 Increases Transforming Growth Factor-{beta} Type III Receptor Expression through CCAAT Enhancer-Binding Protein {delta} in Osteoblasts. Mol. Endocrinol. 21: 2713-2724 [Abstract] [Full Text]  
• Janssens, K, Vanhoenacker, F, Bonduelle, M, Verbruggen, L, Van Maldergem, L, Ralston, S, Guanabens, N, Migone, N, Wientroub, S, Divizia, M T, Bergmann, C, Bennett, C, Simsek, S, Melancon, S, Cundy, T, Van Hul, W (2006). Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment. J. Med. Genet. 43: 1-11 [Abstract] [Full Text]  
• Janssens, K., ten Dijke, P., Janssens, S., Van Hul, W. (2005). Transforming Growth Factor-{beta}1 to the Bone. Endocr. Rev. 26: 743-774 [Abstract] [Full Text]  
• Boyden, L. M., Mao, J., Belsky, J., Mitzner, L., Farhi, A., Mitnick, M. A., Wu, D., Insogna, K., Lifton, R. P. (2002). High Bone Density Due to a Mutation in LDL-Receptor-Related Protein 5. NEJM 346: 1513-1521 [Abstract] [Full Text]  
• Pereira, R. C., Economides, A. N., Canalis, E. (2000). Bone Morphogenetic Proteins Induce Gremlin, a Protein That Limits Their Activity in Osteoblasts. Endocrinology 141: 4558-4563 [Abstract] [Full Text]  
• Pereira, R. C., Durant, D., Canalis, E. (2000). Transcriptional regulation of connective tissue growth factor by cortisol in osteoblasts. Am. J. Physiol. Endocrinol. Metab. 279: E570-E576 [Abstract] [Full Text]  
• Blanquaert, F., Pereira, R. C., Canalis, E. (2000). Cortisol inhibits hepatocyte growth factor/scatter factor expression and induces c-met transcripts in osteoblasts. Am. J. Physiol. Endocrinol. Metab. 278: E509-E515 [Abstract] [Full Text]  
• Abu, E. O., Horner, A., Kusec, V., Triffitt, J. T., Compston, J. E. (2000). The Localization of the Functional Glucocorticoid Receptor {alpha} in Human Bone. J. Clin. Endocrinol. Metab. 85: 883-889 [Abstract] [Full Text]  
• Ji, C., Chen, Y., McCarthy, T. L., Centrella, M. (1999). Cloning the Promoter for Transforming Growth Factor-beta Type III Receptor. BASAL AND CONDITIONAL EXPRESSION IN FETAL RAT OSTEOBLASTS. J. Biol. Chem. 274: 30487-30494 [Abstract] [Full Text]  
• Pereira, R. C., Jorgetti, V., Canalis, E. (1999). Triiodothyronine induces collagenase-3 and gelatinase B expression in murine osteoblasts. Am. J. Physiol. Endocrinol. Metab. 277: E496-E504 [Abstract] [Full Text]  
• Pereira, R. C., Canalis, E. (1999). Parathyroid Hormone Increases mac25/Insulin-Like Growth Factor-Binding Protein-Related Protein-1 Expression in Cultured Osteoblasts. Endocrinology 140: 1998-2003 [Abstract] [Full Text]  
• Blanquaert, F., Delany, A. M., Canalis, E. (1999). Fibroblast Growth Factor-2 Induces Hepatocyte Growth Factor/Scatter Factor Expression in Osteoblasts. Endocrinology 140: 1069-1074 [Abstract] [Full Text]  
• Pereira, R. C., Blanquaert, F., Canalis, E. (1999). Cortisol Enhances the Expression of mac25/Insulin-Like Growth Factor-Binding Protein-Related Protein-1 in Cultured Osteoblasts. Endocrinology 140: 228-232 [Abstract] [Full Text]  
• Chang, D. J., Ji, C., Kim, K. K., Casinghino, S., McCarthy, T. L., Centrella, M. (1998). Reduction in Transforming Growth Factor beta  Receptor I Expression and Transcription Factor CBFa1 on Bone Cells by Glucocorticoid. J. Biol. Chem. 273: 4892-4896 [Abstract] [Full Text]  
• Franchimont, N., Gangji, V., Durant, D., Canalis, E. (1997). Interleukin-6 with Its Soluble Receptor Enhances the Expression of Insulin-Like Growth Factor-I in Osteoblasts. Endocrinology 138: 5248-5255 [Abstract] [Full Text]  
• Ji, C., Casinghino, S., McCarthy, T. L., Centrella, M. (1997). Multiple and Essential Sp1 Binding Sites in the Promoter for Transforming Growth Factor-beta Type I Receptor. J. Biol. Chem. 272: 21260-21267 [Abstract] [Full Text]  
• Franchimont, N., Durant, D., Canalis, E. (1997). Interleukin-6 and Its Soluble Receptor Regulate the Expression of Insulin-Like Growth Factor Binding Protein-5 in Osteoblast Cultures. Endocrinology 138: 3380-3386 [Abstract] [Full Text]  
• Franchimont, N., Rydziel, S., Delany, A. M., Canalis, E. (1997). Interleukin-6 and Its Soluble Receptor Cause a Marked Induction of Collagenase 3 Expression in Rat Osteoblast Cultures. J. Biol. Chem. 272: 12144-12150 [Abstract] [Full Text]  
• Lian, J. B., Shalhoub, V., Aslam, F., Frenkel, B., Green, J., Hamrah, M., Stein, G. S., Stein, J. L. (1997). Species-Specific Glucocorticoid and 1,25-Dihydroxyvitamin D Responsiveness in Mouse MC3T3-E1 Osteoblasts: Dexamethasone Inhibits Osteoblast Differentiation and Vitamin D Down-Regulates Osteocalcin Gene Expression. Endocrinology 138: 2117-2127 [Abstract] [Full Text]  
• Koli, K. M., Arteaga, C. L. (1997). Processing of the Transforming Growth Factor beta Type I and II Receptors. BIOSYNTHESIS AND LIGAND-INDUCED REGULATION. J. Biol. Chem. 272: 6423-6427 [Abstract] [Full Text]  
• Centrella, M., Ji, C., Casinghino, S., McCarthy, T. L. (1996). Rapid Flux in Transforming Growth Factor-beta Receptors on Bone Cells. J. Biol. Chem. 271: 18616-18622 [Abstract] [Full Text]  
• Gabbitas, B., Pash, J. M., Delany, A. M., Canalis, E. (1996). Cortisol Inhibits the Synthesis of Insulin-like Growth Factor-binding Protein-5 in Bone Cell Cultures by Transcriptional Mechanisms. J. Biol. Chem. 271: 9033-9038 [Abstract] [Full Text]  
• Delany, A. M., Jeffrey, J. J., Rydziel, S., Canalis, E. (1995). Cortisol Increases Interstitial Collagenase Expression in Osteoblasts by Post-transcriptional Mechanisms. J. Biol. Chem. 270: 26607-26612 [Abstract] [Full Text]  
• Canalis, E., Gabbitas, B. (1995). Skeletal Growth Factors Regulate the Synthesis of Insulin-like Growth Factor Binding Protein-5 in Bone Cell Cultures. J. Biol. Chem. 270: 10771-10776 [Abstract] [Full Text]  
• Saito, T., Kinoshita, A., Yoshiura, K.-i., Makita, Y., Wakui, K., Honke, K., Niikawa, N., Taniguchi, N. (2001). Domain-specific Mutations of a Transforming Growth Factor (TGF)-beta 1 Latency-associated Peptide Cause Camurati-Engelmann Disease Because of the Formation of a Constitutively Active Form of TGF-beta 1. J. Biol. Chem. 276: 11469-11472 [Abstract] [Full Text]